Eli Lilly may face FDA warning letter after recent inspection at COVID-19 antibody plant found more issues: report

Eli Lilly may face FDA warning letter after recent inspection at COVID-19 antibody plant found more issues: report
kblankenship
Wed, 10/21/2020 – 08:46